POSA3 Comparative Efficacy of Anti-Vascular Endothelial Growth Factor (ANTI-VEGF) Agents for Treatment of Neovascular Age-Related Macular Degeneration (NAMD): A Systematic Review and Network Meta-Analysis
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.078
https://www.valueinhealthjournal.com/article/S1098-3015(21)01873-8/fulltext
Title :
POSA3 Comparative Efficacy of Anti-Vascular Endothelial Growth Factor (ANTI-VEGF) Agents for Treatment of Neovascular Age-Related Macular Degeneration (NAMD): A Systematic Review and Network Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01873-8&doi=10.1016/j.jval.2021.11.078
First page :
Section Title :
Open access? :
No
Section Order :
10404